Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2021.839850 Endocrinology Retraction Retraction: Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2 Frontiers Editorial Office *

Approved by: Pierre De Meyts, Université Catholique de Louvain Brussels, Belgium

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology

 30 12 2021 2021 12 839850 20 12 2021 20 12 2021 Copyright © 2021 Frontiers Editorial Office 2021 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2 by Liu X., Zhang Y., Liang H. and Xu Y. (2020) Front. Endocrinol. 11:522340. doi: 10.3389/fendo.2020.522340

The journal and Chief Editors retract the 27 November 2020 article cited above.

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article. ​​

This retraction was approved by the Chief Editors of Frontiers in Endocrinology and the Chief Executive Editor of Frontiers. The authors agreed with this retraction.